AventaMed® Designs and Develops Innovative ENT Medical Devices

AventaMed develops novel medical devices which streamline surgery, allowing procedures to move out of the Operating Room and into new sites of service, such as the doctor’s office or clinic.

AventaMed was crowned Seedcorn’s Overall Winner for the Best Early Stage Company in 2014 and Emerging Medtech Company of the Year, Irish Medical Device Association (IMDA) in 2015.

The AventaMed team have successfully completed clinical studies, gained ISO 13485 certification, and obtained CE Mark for the Solo+™ device in Europe. The Solo+™ device has also received 510(k) clearance from the U.S. Food and Drug Administration, for use in paediatric patients aged 6 months and older.

Product Info

Solo+™ is CE Marked and available to surgeons in Europe. In addition, the Food and Drug Administration (FDA) in the US has given 510(k) clearance to the product for use in paediatric patients aged 6 months and older.

Contact us for more information.

In 2023 AventaMed was acquired by KARL STORZ, a renowned global manufacturer and distributor of endoscopes, medical instruments, and devices. This partnership has solidified AventaMed's position in the industry and has opened up new possibilities for further innovation and advancement.

Clinical Advisors

AventaMed’s clinical advisors are world renowned otolaryngologists with a special interest in otitis media. Our dedicated Clinical Advisors are experts in Otology and have strong connections to medical associations around the world.

Dr. Joe Kerschner

Dr. Joseph Kerschner is a pediatric otolaryngologist with over 2 decades of continuous funding from the National Institutes of Health in the area of otitis media research. He served as Dean of the School of Medicine at the Medical College of Wisconsin (MCW) from 2011 through 2024. Dr. Kerschner also served as MCW’s Inaugural Provost from 2017-2024. He transitioned to the role of Emeritus Dean in 2025 and has since moved to the positions of Senior Partner at Chartis Consulting, CEO of OtoNano, LLC, and a Senior Scholar at the New York Academy of Medicine. In these roles, Dr. Kerschner maintains an active research laboratory and as a leader in academic medicine.

Previously, Dr. Kerschner has held numerous leadership roles, including serving as Chair of the Council of Deans for the Association of American Medical Colleges (AAMC) and Chair of the AAMC’s Board of Directors. Dr. Kerschner maintains an active membership on numerous professional and honorary societies and has held critical leadership roles in otolaryngology including President of the American Society of Pediatric Otolaryngology (ASPO), President of the International Society for Otitis Media (ISOM), Editor-in-Chief for the International Journal of Pediatric Otorhinolaryngology and Senior Examiner for the American Board of Otolaryngology.

Prof. Antony Narula

Prof. Narula was a consultant otorhinolaryngologist at St Mary’s Hospital, Paddington, Charing Cross Hospital and Hammersmith Hospital. He was also an Honorary Consultant at Chelsea & Westminster and Royal Brompton Hospitals and took early retirement in December 2014. He has a special interest in children with ear, nose and throat disorders and hearing problems. He was elected the President of the British Society of Otology 2010 – 2012. He was awarded an Honorary Professorship from Middlesex Hospital in 2003 and has been national clinical lead for ENT for the NHS Modernisation Agency, winning a Beacon award in 1999 for waiting list management and innovation.

He has an interest in medical politics and served as President of both the Association of Otolaryngologists in Training and the Young Consultant Otolaryngologists. He was editor of the CME Bulletin Otolaryngology and instigated a diploma course for GPs to learn more about Otolaryngology (DepENT). He was elected to the Council of the Royal College of Surgeons in 2004 where he was the Honorary Treasurer and served as President of ENT UK from 2015-2017. Prof. Narula took early retirement from his Government practice and continues in private practice where he’s also a Clinical Advisor to Audelation, Ltd. as well as a Clinical ENT Advisor to Ufonia, Ltd.

Dr. Mat Daniel

Dr. Mat Daniel is a Consultant Paediatric Otorhinolaryngologist in Nottingham, UK. He trained in the East Midlands and in Sydney and obtained a PhD in the fields of Glue Ear microbiology / biofilms and drug delivery. He has a master’s degree in Coaching, a master’s degree in Medical Education, and is the undergraduate lead for ENT at The University of Nottingham. He is involved in a variety of research projects including clinical trials.